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Abstract
Two types of automated solid phase extraction (SPE) were assessed for the determination of 
human exposure to fentanyls in urine. High sensitivity is required to detect these compounds 
following exposure because of the low dose required for therapeutic effect and the rapid clearance 
from the body for these compounds. To achieve this sensitivity, two acceptable methods for the 
detection of human exposure to seven fentanyl analogs and three metabolites were developed 
using either off-line 96-well plate SPE or on-line SPE. Each system offers different advantages: 
off-line 96-well plate SPE allows for high throughput analysis of many samples, which is needed 
for large sample numbers, while on-line SPE removes almost all analyst manipulation of the 
samples, minimizing the analyst time needed for sample preparation. Both sample preparations 
were coupled with reversed phase liquid chromatography and isotope dilution tandem mass 
spectrometry (LC-MS/MS) for analyte detection. For both methods, the resulting precision was 
within 15%, the accuracy within 25%, and the sensitivity was comparable with the limits of 
detection ranging from 0.002-0.041ng/mL. Additionally, matrix effects were substantially 
decreased from previous reports for both extraction protocols. The results of this comparison 
showed that both methods were acceptable for the detection of exposures to fentanyl analogs and 
metabolites in urine.
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1. Introduction
Fentanyls, potent opioid analgesics, have been used for chronic pain treatment, for palliative 
care, and for use as an anesthetic. Since the initial synthesis of fentanyl in 1960 by Janssen 
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Pharmaceuticals, multiple analogs have been developed with varying potencies for use in the 
medical and veterinary fields. Additionally, analogs with no approved medical use have been 
synthesized and sold illegally under several names including “China White” [1]. Overdose 
cases have been reported in California, Illinois, and Pennsylvania; resulting in 
hospitalization and, in some cases, death [2-4]. Fentanyls have also been reported to have 
applications as incapacitating agents [5, 6].
Clinical manifestations from a significant exposure to fentanyl, which include euphoria, 
sedation, and respiratory depression, are the same as exposure to other opioids such as 
morphine and heroin. Thus, symptomology alone cannot be used to differentiate among 
exposure to different opioids; therefore, a selective analytical method is needed to 
distinguish fentanyl exposure from other opioids. The high potency of fentanyls, 50-100 
times more potent than morphine, along with the low renal clearance of fentanyl analogs, 
results in low concentrations (0.8 ng/mL-4 ng/mL) of the intact fentanyl excreted via urine 
following therapeutic doses [7]. The biological half-life of fentanyl is 1-3.5 hours [8]; 
however, the nor-metabolite, the oxidative n-dealkylation at the piperdine nitrogen of the 
parent compound, has been detected at concentrations of 0.3 to 0.7 ng/mL up to 96 hours 
following therapeutic doses [9]. It is important to note that the common nor-metabolites are 
not unique to each fentanyl analog; therefore, to correctly identify the exposure agent, the 
native compound of all suspected fentanyls must be also monitored, (e.g. sufentanil and 
alfentanil both metabolize to the metabolite norsufentanil) [10-12].
Detection of fentanyls and their corresponding nor-metabolites has been used previously to 
confirm exposures. Analysis of fentanyl in biological matrices has been achieved using 
immunoassays; but these tests are prone to cross-reactivity issues, or are not able to detect 
multiple analogs [11, 13, 14]. Analytical techniques such as liquid chromatography with 
ultraviolet detection (LC-UV), gas chromatography with nitrogen phosphorous detection, 
gas chromatography-mass spectrometry (GC-MS) and liquid chromatography tandem mass 
spectrometry (LC-MS/MS) [15] have also been used to successfully quantitate fentanyls. LC 
analysis has been preferred over GC because GC analysis requires a derivitization step 
[16].Tandem mass spectrometry (MS/MS) has proven to be a valuable tool for fentanyl 
detection because it achieves high selectivity between fentanyl, its analogs, and the 
metabolites while maintaining low detection limits (estimated range from 0.003ng/mL to 
0.027 ng/mL) [17].
To obtain high sensitivity, sample preparation and clean-up is often required before LC-
MS/MS analysis. Although fentanyl compounds have been successfully extracted from 
biological matrices using liquid-liquid extraction (LLE) [15, 18], these extractions were time 
consuming and required large volumes of solvents. Solid phase extraction (SPE) [16, 17] has 
been used for the isolation of fentanyls from biological matrices with success, and has 
several benefits over other sample preparation approaches, including less solvent use, 
smaller sample volume requirements, and it is easily automated.
Automation of solid phase extraction allows a large number of samples to be prepared with 
minimum variability while maintaining high levels of productivity and sample throughput. 
Applications using automated 96-well plate off-line SPE have been documented in many 
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publications [19-22], including fentanyl analysis in plasma [23]. The use of on-line SPE 
automation has further minimized the steps required by the analyst for sample preparation. 
Multiple methods using commercially available on-line SPE systems have demonstrated 
great success [24-26]. Described in this paper is the comparison of off-line SPE with on-line 
SPE for the automated sample preparation of human urine before the analysis and 
quantitation of seven fentanyls and three nor-metabolites using LC-MS/MS.
2. Materials and Methods
2.1 Chemicals, standards, and reagents
Fentanyl, norfentanyl, fentanyl-d5, and norfentanyl-d5 were purchased from Cerilliant 
(Round Rock, TX). Carfentanil, sufentanil, norsufentanil, norcarfentanil, and their 
corresponding N-phenyl-d5 labeled forms were custom synthesized by Battelle Laboratories 
(Columbus, OH). The remaining analytical standards, lofentanil, alfentanil, 3-
methylfentanil, and α-methylfentanil, were generous gifts from a variety of sources listed in 
the acknowledgements. High-performance liquid chromatography (HPLC)-grade methanol 
and acetonitrile were purchased from Tedia Company, Inc. (Fairfield, OH). Formic acid 
(99%) and ammonium hydroxide (28.58%) were purchased from Sigma Aldrich (Pittsburgh, 
PA). Deionized water (>18mΩ) was prepared on-site using an installed water purification 
system (Aqua Solutions, Inc., Jasper, GA).
2.2 Calibrator, Internal Standard, and Quality Control (QC) materials preparation
A working solution containing fentanyl, norfentanyl, sufentanil, norsufentanil, carfentanil, 
norcarfentanil, lofentanil, alfentanil, 3-methylfentanil, and α-methylfentanil each at a 
concentration of 500 ng/mL was prepared in methanol. Calibrators were prepared from this 
solution in pooled human urine from healthy volunteers, purchased from Tennessee Blood 
Services (Memphis, TN) at the following concentrations: 0.010, 0.025, 0.050, 0.10, 0.25, 
0.50, 1.0, 5.0, and 10 ng/mL. Quality control samples (QCs) were prepared in the same 
manner at concentrations of 0.075, 0.75, and 7.5 ng/mL. An internal standard solution was 
prepared as a mixture of the six isotopically labeled versions of fentanyl, norfentanyl, 
sufentanil, norsufentanil, carfentanil, and norcarfentanil each at a concentration of 25 ng/mL 
in methanol.
2.3 Instrumentation
On-line SPE was automated using a Spark Holland Symbiosis (Emmen, The Netherlands) 
system and off-line SPE was automated using a Tomtec Quadra 4 (Hamdem, CT). The 
Symbiosis system was comprised of a refrigerated autosampler, an automated cartridge 
exchanger (ACE), two high pressure dispensing pumps (HPD) for SPE solvent delivery, two 
high performance liquid chromatography (HPLC) pumps, and a column oven. Liquid 
chromatography for both methods was performed using the Symbiosis system. Analytes 
were detected using an Applied Biosystems API 5500 Triple Quadrupole MS (Foster City, 
CA).
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2.4 Sample Preparation
For on-line SPE analysis, 10 μL of the prepared internal standard solution was spiked into 
100 μL of sample, calibrator, or QC in a 300-μL autosampler plate (Eppendorf, Hauppauge, 
NY) and mixed via pipet aspiration and by shaking for five minutes using a Thermo 
Labsystem Wellmix plate mixer (Rochester, NY). Samples were then heat sealed with foil 
and loaded into the autosampler that was cooled to 4°C. An Oasis HLB 30-μm particle, 
10.6-mg bed size cartridge (Waters, Milford, MA) was loaded into the ACE solid phase 
extraction unit. Automated on-line SPE was controlled with Analyst (Applied Biosystems, 
Foster City, CA) and Symbiosis Pro (Spark Holland, Emmen, The Netherlands) companion 
software. SPE cartridges were conditioned with 1 mL of acetonitrile and equilibrated with 1 
mL of aqueous 1% ammonium hydroxide. Fifty microliters of sample, calibrator, or QC was 
loaded onto the cartridge for extraction. The cartridge was then washed with 1 mL of a 
90:10 solution of aqueous 1% ammonium hydroxide: acetonitrile and eluted with the LC 
gradient directly onto the HPLC column for the entirety of the run. Each cartridge was only 
used once.
Off-line SPE samples were prepared by adding 25 μL of the internal standard solution to 500 
μL of sample, calibrator, or QC in a 2-mL 96-well Nunc plate (Thermo Scientific, Rochester, 
NY). This solution was then diluted with 500 μL of aqueous 1% ammonium hydroxide. 
Samples were extracted using a 96-well Oasis HLB 30-μm particle, 30-mg plate (Waters, 
Milford, MA) on the Tomtec Quadra 4 system. Each well was conditioned with 1 mL of 
acetonitrile and equilibrated with 1 mL of aqueous 1% ammonium hydroxide. The entire 
sample mixture was then loaded onto the plate and washed with 1 mL of a 84:15:1 solution 
of water:acetonitrile:ammonium hydroxide. The sample was then eluted with 1 mL of 
acetonitrile containing 1% formic acid. The extracts were evaporated to dryness using a 96-
well Turbovap evaporator (Caliper, Hopkinton, MA) set at 50°C under a continuous flow of 
nitrogen to aid in evaporation. Dried extracts were reconstituted with 50 μL of water and 
briefly mixed via a Thermo Labsystems Wellmix plate mixer (Rochester, NY) and by pipet 
aspiration. The reconstituted samples were transferred to a 300-μL autosampler plate 
(Eppendorf, Hauppauge, NY), heat sealed with foil, and loaded into the autosampler that 
was cooled to 4°C in preparation for LC-MS/MS analysis.
2.5 Chromatography and mass spectrometry conditions
HPLC separation was performed on the Symbiosis system using a 3.0 × 50-mm XTerra MS 
C18 column with 2.5-μm particles (Waters, Milford, MA) maintained at 40°C. The mobile 
phases used for the gradient separation were aqueous 1% formic acid (A) and acetonitrile 
with 1% formic acid (B). Target analytes were separated using a flow rate of 850 μL/min 
with an initial composition of 90% A. After a two min hold, %A was decreased to 40% over 
one min and decreased further to 20% over 5.5 min. Percent A was then increased to 90% 
and held for half a minute. In preparation for the next injection, the column was equilibrated 
for 1.5 min at 90% A for a total run time of 10.5 min. For off-line SPE, the autosampler was 
programmed to inject 10 μL of the extracted sample for LC-MS/MS analysis. For on-line 
SPE, the autosampler was programmed to inject 50 μL of the unextracted sample for SPE-
LC-MS/MS analysis.
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Analytes were measured using turbo-ion-spray MS/MS in positive ion mode. Two 
transitions were monitored for each analyte and one transition was monitored for each 
internal standard. Analyte specific MS parameters are identified in Table 1. Additional 
parameters used during analysis include the following values: curtain gas (CUR), 40 psi; 
nebulizer gas (GS1), 40 psi; turbo gas (GS2), 40 psi; turbo gas temperature (TEM), 550°C; 
collision gas (CAD), 7 producing a pressure reading of nitrogen @ 2.0 × 10-5 Torr; ionspray 
potential (IS), 4200 V; entrance potential (EP), 10 V; and interface heater (IHE), on.
2.6 Data Processing
Data analysis was performed using Analyst software, version 1.5.1. Linear regression 
analysis of the calibrator concentration versus the ratio of the quantification ion area to the 
internal standard ion area was used to determine the calibration curves with a 1/x weighting 
applied. Isotopically-labeled fentanyl, sufentanil, carfentanil, norfentanyl, norsufentanil, and 
norcarfentanil were used as internal standards for the unlabeled analogs. Isotopically-labeled 
carfentanil was used as internal standard for the remaining analytes because its structure and 
chromatographic retention time were similar to many of the fentanyl analogs. Only 
calibration curves with a correlation coefficient of 0.990 or greater were accepted for use. 
Calibrators with insufficient signal were not used for the determination of the calibration 
curve.
2.7 Method Recovery Evaluation
Due to the difference in the on- and off-line SPE systems, extraction recovery could not be 
measured for the on-line SPE method in the same manner as the off-line method. Thus, only 
method recovery was evaluated for the on-line SPE method, while both method and 
extraction recoveries were evaluated for the off-line SPE method. Method recovery was 
evaluated for on-line SPE at two concentration levels using standard solutions at 25 ng/mL 
and 2.5 ng/mL. Water and urine recovery samples were prepared by adding 40 μL of the 
respective standard mixture to 1.0 mL of water or urine. The water recovery sample was 
injected directly onto the LC-MS/MS using an injection volume of 50 μL. The urine 
recovery sample was extracted using the on-line SPE extraction, also with an injection 
volume of 50 μL. Each recovery sample was analyzed in triplicate. The method recovery 
was calculated for the on-line extraction with the following equation:
Method and extraction recoveries for off-line SPE were evaluated similarly using the same 
standard solutions as for on-line recovery experiments. For the urine recovery samples, 
prepared in triplicate, a 20 μL spike of the respective standard mixture was added to 0.5 mL 
of pooled urine from Tennessee Blood Services (Memphis, TN). The samples were 
extracted, concentrated, reconstituted, and analyzed using LC-MS/MS. For the water 
recovery samples, 20 μL of standard mixture was diluted to a total volume of 50 μL with 
water. In addition, a second set of urine recovery samples (urine recovery sample 2) were 
prepared in triplicate from extracted blank urine. These samples were spiked with 20 μL of 
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standard mixture, concentrated, reconstituted, and analyzed using LC-MS/MS. Method 
recovery was calculated as with on-line SPE, with the above equation. Extraction recovery 
was calculated with the following equation:
2.8 Matrix Effects
Matrix effects were evaluated using an infusion approach as described previously in 
literature [27]. The concentration of the infused standard solution was 11 ng/mL with a flow 
rate of 16 μL/min coupled to the LC flow of 850 μL/min. Extracted pooled human urine or 
water was injected into this system and the individual transition responses at the appropriate 
retention times were measured. Matrix effects for each compound were calculated using the 
following equation:
2.9 Limit of Detection Calculations
An insufficient number of positive responses from blank urines precluded calculation of the 
standard deviations of the blank (S0) from direct measurements. Therefore, S0 for each 
analyte in this method was extrapolated from the plot of the standard deviations of the 
lowest four standards versus their respective concentrations. S0, the y-intercept of the linear 
regression analysis of these data points, was multiplied by three to determine the limits of 
detection [28].
2.10 Reference Range Samples
Sixty reference range samples were acquired from Tennesee Blood Services (Memphis, TN). 
Because no personal identifiers were available for theses samples, they were exempt from 
human subjects research review. These samples were process in a manner identical to the 
blank, standard, and quality control materials.
3. Results and Discussion
3.1 Mass Spectra and Liquid Chromatography
Two automated SPE methods for the analysis of several fentanyls or corresponding nor-
metabolites in urine were developed and compared. Seven different fentanyl compounds and 
three corresponding nor-metabolites, shown in Figure 1, were included in this assay. Initial 
mass spectrometric parameters were determined by individually infusing each compound 
into the electrospray source and optimizing for response. From this data, two mass 
spectrometric transitions were selected per compound to achieve maximum sensitivity and 
minimal matrix interferences. Because the structural isomers, α-methylfentanil and 3-
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methylfentanil, were not separated chromatographically, unique quantitation transitions were 
selected for each compound to prevent signal contribution from one to the other. To ensure 
comparability of both on-line and off-line SPE sample analyses, the identical MS transitions 
and parameters were used for both experiments.
Chromatographic separation was designed to be used with both on- and off-line extractions. 
Because the nor-metabolites are significantly more polar than the fentanyl analogs, the 
reversed phase separation was optimized to retain the nor-metabolites on column as long as 
possible to reduce matrix interferences. The chromatograms for both the on- and off-line 
analysis are shown in Figure 2. The peaks seen in the blank for the off-line chromatograph 
were due to contribution from the internal standard for those compounds. These were seen to 
be less than 1% of the lowest calibrator and thus deemed acceptable. It was critical to wash 
the column with high organic to prevent matrix effects from the previous sample. In addition 
the column must be equilibrated prior to each injection because norfentanyl and 
norcarfentanil were sensitive to the organic content of the starting solvents and eluted in the 
void volume when the system was not fully equilibrated. This resulted in a total LC run time 
of 10.5 minutes for both methods. The addition of formic acid to the mobile phase reduced 
tailing and improved peak shape. To elute matrix interferences from the column the organic 
content of the mobile phase was increased to 80% after the elution of the compounds of 
interest. The retention factors for this analysis ranged from 5 to 6 and demonstrated 
sufficient retention of these analytes, particularly the nor-metabolites, on this column.
3.2 Automated Sample Preparation
Sample extraction parameters were established using the on-line SPE system. This approach 
streamlined the screening of multiple SPE sorbents, optimization of wash steps, and 
evaluation of pH without the need to concentrate and/or reconstitute samples. Initial sorbent 
testing showed OASIS HLB, used previously [17], and the HySphere Resin, a strong 
hydrophobic polymeric solid phase extraction sorbent, to work better than ion exchange 
sorbents. Upon further evaluation, the OASIS HLB was selected as peak broadening was 
reduced when using on-line SPE coupled with reversed phase chromatography. Both acidic 
and basic extraction conditions were investigated. Basic conditions using aqueous 1% 
ammonium hydroxide for conditioning and wash steps were determined to be optimal, 
corroborating a previous study [29]. A wash step with 15% acetonitrile effectively removed 
matrix interferences from the off-line SPE cartridge, but resulted in early elution of the nor-
metabolites for the on-line SPE extraction. An adjustment to a wash of 10% acetonitrile for 
the on-line SPE protocol minimized this issue.
Off-line extraction parameters were adapted from the on-line extraction protocol. The 
OASIS HLB 96-well plate with 30-mg bed size was selected as it was the closest match to 
the bed size of the on-line SPE cartridge with respect to the sample size. The off-line wash 
step remained at 15% acetonitrile because no negative impact was seen in the 
chromatography. The off-line sample was diluted with 0.5 mL of 1% ammonium hydroxide 
in water prior to loading. Although no difference in method recovery was seen with this 
addition, data not shown, this addition was done as a precautionary measure since the pH of 
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urine can vary. Since the on-line method does not have a concentration step, a pH adjustment 
would negatively affect the LOD and thus was not done.
3.3 Recovery and Matrix Effects
Once both extraction methods were established, the recoveries of both methods were 
measured. Extraction recovery for the off-line SPE protocol was measured to be from 
62-98%.The extraction recovery for the on-line method could not be directly measured due 
to system design, so instead, the method recovery was reported, and it is impacted by such 
factors as extraction recovery, concentration stability (for off-line SPE only), and matrix 
effects. Method recovery ranged from 8-39% for the on-line SPE method and 18-80% for 
the off-line SPE method with 100% being ideal (Table 2). This was true for both 
concentration levels investigated, however only the higher concentration is shown in Table 2. 
Matrix effects were also evaluated because these can result in ion suppression and have been 
a significant concern in previous publications [17]. To ensure comparability of the matrix 
effect measurement between both preparation methods an infusion approach was used. 
Matrix effects from the on-line SPE protocol were minimal for both analogs and metabolites 
(Table 2) and may have resulted primarily from the dilution of the sample throughout the 
extraction process. Although matrix effects were not reduced as significantly for off-line 
SPE, the nor-metabolites matrix effects were shown to be much improved (Table 2), as 
compared to previously reported values in the literature [17]. This decrease in suppression 
was most likely due to the use of basic extraction conditions, which allowed interfering 
matrix components to be washed from the cartridge. The difference in matrix effects 
between the two methods is expected due to the concentration step in the off-line method, 
resulting in more matrix being put on column.
3.4 Method Characterization
This analytical method was characterized for both on- and off-line SPE by assessing 10 sets 
of quality control samples prepared in pooled urine at spiked concentrations of 7.5 ng/mL 
and 0.75 ng/mL. These quality control levels were selected based on their correlation to 
anticipated exposure levels in those exposed to non-fatal therapeutic doses, which have been 
reported to be in the range of 0.8-4.0 ng/mL for fentanyl in urine [7]. Calibrators were 
prepared in pooled urine and were extracted and analyzed with the quality control samples 
over the course of two months. Sensitivity, accuracy, and precision were calculated based on 
the quantitation ion transition. As shown in Table 3, the imprecision, as defined by the 
relative standard deviation, ranged from 6-23% for the quality control samples prepared by 
the on-line method. The accuracy for the samples analyzed was within ±15% for all QCs. 
For the off-line method, the imprecision was less than 16% for all analytes, and the accuracy 
was within ±16%. This data shows that the reproducibility and accuracy for the off-line and 
on-line methods are comparable.
The estimated LODs for the on-line method were calculated to range from 0.003 ng/mL to 
0.041 ng/mL and the LODs for the off-line method were calculated to range from 0.002 
ng/mL to 0.035 ng/mL. The LODs for the off-line method were lower for norcarfentanil and 
alfentanil, but higher for lofentanil; however, for all other compounds the estimated LODs 
were on the same order of magnitude.
Shaner et al. Page 8
J Chromatogr B Analyt Technol Biomed Life Sci. Author manuscript; available in PMC 2016 March 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In addition, the linear range for the off-line method exhibited an upper limit of 5.0 ng/mL for 
norfentanyl and norsufentanil rather than the upper limit of 10 ng/mL exhibited for the 
majority of the analytes and for the on-line method. This reduced linearity at the high end of 
the calibration range was only seen for the off-line method due to the concentration step and 
the use of larger sample volumes, which resulted in larger on-column concentrations and 
exceeded the linear range of the detector. Based on the estimated LODs and the linearity for 
each analyte, the reportable range for the on-line method was 0.050 ng/mL to 10 ng/mL and 
the off-line method was 0.050 ng/mL to 5.0 ng/mL (Table 4).
A reference range of 60 random urine samples was analyzed to measure any endogenous 
interferences in the general population. Endogenous interfences can be derived from various 
sources, including diet, cosmetic products, or other environmental sources. For the 60 
samples measured using both methods, no interferences were observed for any compound. 
This indicates that this method is selective for all fentanyl analogs and metabolites. Thus 
analysis of unknown urine samples should not result in false positives.
Two methods for automated SPE were developed and compared for the detection of fentanyl 
analogs and metabolites in urine. Both methods provided low detection limits and acceptable 
accuracy, while presenting some precision problems for select analytes for the on-line 
analysis. The development of both off- and on-line automated SPE methods allows an 
analyst to choose between high throughput for many samples and minimizing analyst 
interactions with the samples.
4. Conclusions
The on- and off-line SPE method comparison showed two effective methods for the 
detection of fentanyl analogs and metabolites in urine. Both methods had comparable 
LOD's, while the on-line method had a broader linear range, the off-line method provided 
overall better recoveries. Because therapeutic doses typically result in 0.8 ng/mL to 4 ng/mL 
of fentanyls in urine, both methods presented here have the sensitivity and selectivity 
necessary to assess low to moderate concentrations of fentanyl and its analogs in human 
urine. Therefore, the selection of either the on- or off-line SPE may be based on the desired 
compounds in addition to the availability of laboratory resources and technician expertise. In 
future studies, the selection of a more orthogonal chromatographic procedure to the solid 
phase extraction may improve the on-line extraction recovery, if additional sensitivity is 
desired. Both methods could be improved further by expanding the linear range, so high 
urinary concentrations resulting from toxic or fatal doses can be measured and assist with 
forensic diagnosis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This study was possible due to the support of a number of people and organizations who provided analytical 
standards for these assays. For these valuable contributions, we would like to thank Dr. Rita McManamon, Atlanta 
Fulton County Zoo (Atlanta, GA); Dr. Jerry Thomas, Centers for Disease Control and Prevention (Atlanta, GA); the 
Shaner et al. Page 9
J Chromatogr B Analyt Technol Biomed Life Sci. Author manuscript; available in PMC 2016 March 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DEA Western Laboratory (San Francisco, CA); Dr. C. Randall Clark, School of Pharmacy, Auburn University 
(Auburn, AL); Dr. Thomas Tobin, Department of Veterinary Science, University of Kentucky (Lexington, KY); Dr. 
France Varin, Faculty of Pharmacy, University of Montreal (Quebec, Canada); Dr. Jim Baron, Battelle Columbus 
Laboratories (Columbus, OH); and the NIDA Drug Supply Program.
References
1. Kram TC, Cooper DA, Allen AC. Analytical Chemistry. 1981; 53:1379–1386.
2. Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS. Clinical toxicology. 2008; 
46:501–506. [PubMed: 18584361] 
3. Hibbs J, Perper J, Winek CL. JAMA. 1991; 265:1011–1013. [PubMed: 1867667] 
4. Ayres WA, Starsiak MJ, Sokolay P. Jounrnal of Psychoactive Drugs. 1981; 13:91–93.
5. National Research Council, Chemical and Biological Terrorism:Research and Development to 
Improve Civilian Medical Response. National Academy Press; Washington DC: 1999. 
6. Riches JR, Read RW, Black RM, Cooper NJ, Timperley CM. J Anal Toxicol. 2012; 36:647–656. 
[PubMed: 23002178] 
7. Strano-Rossi S, Alvarez I, Tabernero MJ, Cabarcos P, Fernandez P, Bermejo AM. Journal of applied 
toxicology : JAT. 2011; 31:649–654. [PubMed: 21132842] 
8. Skulska A, Kala M, Parcezewski A. Przeql Lek. 2005; 62:581–584.
9. Silverstein JH, Rieders MF, McMullin M, Schumlman S, Zahl K. Anesth Analg. 1993; 76:618–621. 
[PubMed: 8452277] 
10. Meert TF. Pharm World Science. 1996; 18:1–15.
11. Poklis A. Clinical toxicology. 1995; 33:439–447. [PubMed: 7650768] 
12. Valaer AK, Huber T, Andurkar SV, Clark CR, DeRuiter J. Journal of Chromatographic Science. 
1997; 35:461–466. [PubMed: 9336954] 
13. Snyder ML, Jarolim P, Melanson SE. Clinica chimica acta; international journal of clinical 
chemistry. 2011; 412:946–951.
14. Wang G, Huynh K, Barhate R, Rodrigues W, Moore C, Coulter C, Vincent M, Soares J. Forensic 
science international. 2011; 206:127–131. [PubMed: 20801588] 
15. Huynh NH, Tyrefors N, Ekman L, Johansson M. Journal of pharmaceutical and biomedical 
analysis. 2005; 37:1095–1100. [PubMed: 15862690] 
16. V HAF, Van Nimmen Nadine FJ. Journal of Chromatography A. 2004; 1035:249–259. [PubMed: 
15124818] 
17. Wang L, Bernert JT. Jounal of Analytical Toxicology. 2006; 30:335–341.
18. Cooreman S, Deprez C, Martens F, Van Bocxlaer J, Croes K. Journal of separation science. 2010; 
33:2654–2662. [PubMed: 20658494] 
19. Allanson JP, Biddlecombe RA, Jones AE, Pleasance S. Rapid Communications in Mass 
Spectrometry. 1996; 10:811–816.
20. Simpson H, Berthemy A, Buhrman D, Burton R, Newton J, Kealy M, Wells D, Wu D. Rapid 
Communications in Mass Spectrometry. 1998; 12:75–82. [PubMed: 9470219] 
21. Harrison AC, Walker DK. Journal of pharmaceutical and biomedical analysis. 1998; 16:777–783. 
[PubMed: 9535189] 
22. Zhang H, Henion J. Analytical Chemistry. 1999; 71:3955–3964. [PubMed: 10500482] 
23. Shou WZ, Jiang X, Beato BD, Naidong W. Rapid Communications in Mass Spectrometry. 2001; 
15:466–476. [PubMed: 11268130] 
24. M MA, Jagerdeo Eshwar, LeBeau Marc A, Sibum Martin. Journal of Chromatography B. 2008; 
874:15–20.
25. de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H. Biomedical 
chromatography : BMC. 2012; 26:1461–1463. [PubMed: 22344545] 
26. Wang Y, Qu Y, Bellows CL, Ahn JS, Taylor SW. Bioanalysis. 2012; 4:2141–2152. [PubMed: 
23013396] 
27. Bonfiglio R, King RC, Olah TV, Merkle K. Rapid communications in mass spectrometry : RCM. 
1999; 13:1175–1185. [PubMed: 10407294] 
Shaner et al. Page 10
J Chromatogr B Analyt Technol Biomed Life Sci. Author manuscript; available in PMC 2016 March 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
28. Taylor JK. Quality Assurance of Chemical Measurements, Lewis Publishers, Boca Raton, Florida. 
1987
29. Ghassabian S, Moosavi SM, Valero YG, Shekar K, Fraser JF, Smith MT. Journal of 
chromatography B, Analytical technologies in the biomedical and life sciences. 2012; 903:126–
133. [PubMed: 22841553] 
Shaner et al. Page 11
J Chromatogr B Analyt Technol Biomed Life Sci. Author manuscript; available in PMC 2016 March 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Chemical structures of fentanyl analogs and metabolites. Analytes with a * have 
matched isotopically labeled internal standards (D5)
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Figure 2. 
LC-MS/MS chromatrogram of Fentanyl metabolites and analogs spiked into blank pooled 
urine for (A) on-line and (B) off-line SPE. Analytes in order of elution are 1 – norfentanyl, 2 
– norcarfentanil, 3 – norsufentanil, 4 – alfentanil, 5 – fentanyl, 6 – 3-methyl fentanil, 7 – 
carfentanil, 8 – α-methyl fentanil, 9 – lofentanil, 10 – sufentanil, Fentanyl-d5 is included as 
a relative intensity reference point.
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Table 2
Method recovery of fentanyl metabolites and analogs spiked into pooled human urine and extracted using both 
on- and off-line SPE protocols. Investigation of matrix effects for fentanyl metabolites and analogs using post 
column infusion for both on- and off-line SPE protocols. A value of 0 indicates no matrix effects, while a 
positive value indicates suppression and a negative value indicates enhancement.
On-line Recovery (%) Off-line Recovery (%) On-line Matrix Effects (%) Off-line Matrix Effects (%)
Norfentanyl 8.01 69.3 -13.4 4.9
Norsufentanil 17.6 68.2 9.7 15.0
Norcarfentanil 8.31 83.5 8.7 -16.3
Fentanyl 32.9 42.0 -3.4 74.9
Sufentanil 33.6 37.7 2.7 68.0
Carfentanil 33.7 39.2 -7.3 41.9
Lofentanil 39.8 31.7 -20.0 62.2
Alfentanil 30.2 80.6 3.1 52.4
α-methylfentanil 31.4 18.5 -16.7 -100.0
3-methylfentanil 39.9 22.7 10.0 15.0
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Table 4
LOD and reportable range for each analyte for the on- and off-line SPE methods. The LOD and reportable 
range were based upon the n=10 runs for both methods. The lower range was determined by the lowest 
calibrator with precision and accuracy within 25%, and the upper range was determined by the highest 
calibrator that allowed for a linear calibration curve (R2=0.990).
On-line LOD (ng/mL) Off-line LOD (ng/mL) On-line Reportable Range 
(ng/mL)
Off-line Reportable Range 
(ng/mL)
Norfentanyl 0.022 0.012 0.050-10 0.025-5.0
Norsufentanil 0.009 0.002 0.010-10 0.010-5.0
Norcarfentanil 0.041 0.007 0.050-10 0.025-10
Fentanyl 0.007 0.007 0.025-10 0.010-10
Sufentanil 0.003 0.004 0.010-10 0.010-10
Carfentanil 0.008 0.008 0.025-10 0.010-10
Lofentanil 0.008 0.028 0.025-10 0.050-10
Alfentanil 0.015 0.006 0.050-10 0.010-10
α-methylfentanil 0.013 0.035 0.025-10 0.050-10
3-methylfentanil 0.029 0.020 0.025-10 0.050-10
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